Stay updated on Exemestane in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Exemestane in NSCLC Clinical Trial page.

Latest updates to the Exemestane in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a change to the ClinicalTrials.gov site build rather than any modification to the study details.SummaryDifference0.1%

- Check9 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision indicator updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 and removed the prior funding-status notice while preserving existing trial content; no trial details are changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedA site-wide funding/status notice was added, noting potential delays and that the NIH Clinical Center is open. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Exemestane in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exemestane in NSCLC Clinical Trial page.